GE goes to market with new MRI co-designed with the NFL

GE Healthcare has won FDA 510(k) clearance to sell a 3-T MRI system developed with input from several neuroimaging research institutions as well as the National Football League.

The wide- yet short-bore system, called Signa Premier, has been in the works for four years and incorporates technology designed to detect biomarkers of concussion and other forms of mild traumatic brain injury, according to a press release.

GE says the system includes digital radiofrequency transmit-and-receive architecture, enabling imagers to acquire patient data from multiple high channel-density surface coils all at once.

Eric Stahre, PhD, president and CEO of the company’s global MRI operation, says the new system “will help clinicians push the boundaries of what’s possible with MR.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.